Physician

Steven D Ness, M.D.

According to 2025 Medicare claims, Steven Ness, M.D. (NPI: 1700844206) practices ophthalmology in the Providence-Warwick, RI-MA market, with the plurality of this provider's patient population coming from Bristol, MA. This provider's primary affiliated billing organization is BOSTON UNIVERSITY EYE ASSOCIATES, INC. (NPI: 1154317865; TIN: 043137333) and primary practice location at 02780-1085. Ness is affiliated with the BMC Integrated Care Services, Inc. (ACO ID: A2666), participating under the MSSP model.

Ness' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 592 traditional Medicare patients, billed 12,470 HCPCS/CPT codes, and received $887,204 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 273 prescription claims across 81 beneficiaries totaling $18,052 in drug costs, led by Brimonidine Tartrate (Brimonidine Tartrate). Open Payments data shows 1 records totaling $107. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$444K$887K2015 Medicare payment: $590,029 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $675,772 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $825,451 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $852,336 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $811,252 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $677,521 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $692,240 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $833,282 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $789,289 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $887,204 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156514,446$590,029
20167094,638$675,772
20177265,298$825,451
20187084,884$852,336
20196184,353$811,252
20205553,545$677,521
20214833,802$692,240
20225454,212$833,282
20235315,337$789,289
202459212,470$887,204

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$9.0K$18K2015 Drug cost: $17,922 (USD; Tot_Drug_Cst)2016 Drug cost: $15,923 (USD; Tot_Drug_Cst)2017 Drug cost: $17,162 (USD; Tot_Drug_Cst)2018 Drug cost: $13,294 (USD; Tot_Drug_Cst)2019 Drug cost: $12,633 (USD; Tot_Drug_Cst)2020 Drug cost: $15,310 (USD; Tot_Drug_Cst)2021 Drug cost: $9,659 (USD; Tot_Drug_Cst)2022 Drug cost: $8,148 (USD; Tot_Drug_Cst)2023 Drug cost: $16,083 (USD; Tot_Drug_Cst)2024 Drug cost: $18,052 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201558254$17,922
201671326$15,923
201772382$17,162
201859250$13,294
201948227$12,633
202066304$15,310
202159220$9,659
202256236$8,148
202372288$16,083
202481273$18,052

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg65674$651
67028Injection of drug into eye167757$91
92014Established patient complete exam of visual system331338$74
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more295471$65
92134Imaging of retina5451,413$29

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Brimonidine TartrateBrimonidine Tartrate482,521$5,232
Prednisolone AcetatePrednisolone Acetate481,933$1,926
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat312,037$633
LatanoprostLatanoprost512,520$578
Timolol MaleateTimolol Maleate11830$452

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$107ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Steven D. Ness, M.D.?

Tedicare shows public-source Medicare data for Steven D. Ness, M.D. (NPI 1700844206), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Steven D. Ness, M.D. have ACO affiliation data?

Steven D. Ness, M.D. is shown with ACO affiliation data for BMC Integrated Care Services, Inc. (MSSP, ACO ID A2666).

What billing organization is linked to Steven D. Ness, M.D.?

Steven D. Ness, M.D. is linked to BOSTON UNIVERSITY EYE ASSOCIATES, INC. (billing NPI 1154317865) in the available physician profile data.

Does Steven D. Ness, M.D. have Open Payments data?

Steven D. Ness, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.